HK1022435A1 - Orally applicable formulation of quinolone or naphthyridone carboxylic acids - Google Patents

Orally applicable formulation of quinolone or naphthyridone carboxylic acids

Info

Publication number
HK1022435A1
HK1022435A1 HK00101449A HK00101449A HK1022435A1 HK 1022435 A1 HK1022435 A1 HK 1022435A1 HK 00101449 A HK00101449 A HK 00101449A HK 00101449 A HK00101449 A HK 00101449A HK 1022435 A1 HK1022435 A1 HK 1022435A1
Authority
HK
Hong Kong
Prior art keywords
quinolone
carboxylic acids
orally applicable
applicable formulation
naphthyridone carboxylic
Prior art date
Application number
HK00101449A
Other languages
English (en)
Inventor
Oliver Vetter
Reinhold Loehr
Matthias Kuhn
Hubert Rast
Martin Scheer
Ernst Heinen
Francisco Cabrera
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of HK1022435A1 publication Critical patent/HK1022435A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK00101449A 1996-08-20 2000-03-08 Orally applicable formulation of quinolone or naphthyridone carboxylic acids HK1022435A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19633480A DE19633480A1 (de) 1996-08-20 1996-08-20 Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren
PCT/EP1997/004302 WO1998007428A1 (de) 1996-08-20 1997-08-07 Oral applizierbare formulierungen von chinolon- oder naphthyridoncarbonsäuren

Publications (1)

Publication Number Publication Date
HK1022435A1 true HK1022435A1 (en) 2000-08-11

Family

ID=7803084

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00101449A HK1022435A1 (en) 1996-08-20 2000-03-08 Orally applicable formulation of quinolone or naphthyridone carboxylic acids

Country Status (17)

Country Link
US (1) US5808076A (xx)
EP (1) EP0920317B1 (xx)
JP (1) JP4338222B2 (xx)
KR (1) KR100493577B1 (xx)
CN (1) CN1113651C (xx)
AR (1) AR008304A1 (xx)
AT (1) ATE260657T1 (xx)
AU (1) AU3942797A (xx)
BR (1) BR9711338B1 (xx)
CA (1) CA2263584C (xx)
DE (2) DE19633480A1 (xx)
DK (1) DK0920317T3 (xx)
ES (1) ES2213829T3 (xx)
HK (1) HK1022435A1 (xx)
MY (1) MY117606A (xx)
TW (1) TW518226B (xx)
WO (1) WO1998007428A1 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100365679B1 (ko) * 2000-04-03 2002-12-26 주식회사 엘지생명과학 기호성이 우수한 엔로프록사신 프리믹스 조성물 및 그제조방법
US6518252B2 (en) * 2000-09-20 2003-02-11 University Of Georgia Research Foundation, Inc. Method of treating aquatic animals with an antimicrobial agent and chelating agent
US20020122824A1 (en) * 2001-01-24 2002-09-05 Francisco Cabrera Solid phase dispersion of quinolone-or naphthyridonecarboxylic acids
US6589955B2 (en) 2001-06-20 2003-07-08 Bristol-Myers Squibb Company Pediatric formulation of gatifloxacin
WO2003031443A1 (en) * 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety
PT1594500E (pt) * 2003-02-10 2010-12-17 Bayer Schering Pharma Ag Tratamento para doenças bacterianas dos órgãos respiratórios por aplicação local de fluoroquinolonas
ES2308171T3 (es) * 2003-04-30 2008-12-01 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Uso de antibioticos hibridos de oxazolidinona-quinolina para el tratamiento del antrax y de otras infecciones.
DE10328666A1 (de) * 2003-06-26 2005-01-13 Bayer Healthcare Ag Tabletten enthaltend Geschmacks-und/oder Aromastoffe
DE10337191A1 (de) * 2003-08-13 2005-03-17 Bayer Healthcare Ag Neue Verwendung von Chinolon-Antibiotika
DE10340485B4 (de) * 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
DE10351448A1 (de) * 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
PL1709044T5 (pl) 2003-12-18 2014-03-31 Morphochem Aktiengesellschaft Fuer Komb Chemie Antybiotyki hybrydowe oksazolidynon-chinolon
US8158797B2 (en) * 2003-12-18 2012-04-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
FR2896416B1 (fr) 2006-01-24 2010-08-13 Vetoquinol Composition anti-infectieuse comprenant un compose de type pyrido (3,2,1-ij)-benzoxadiazine
CN100360131C (zh) * 2006-01-24 2008-01-09 新昌国邦化学工业有限公司 一种掩味恩诺沙星的生产方法
KR101148501B1 (ko) * 2007-06-08 2012-05-25 광동 하이나팜 파마슈티칼 씨오., 엘티디. 엔로플록사신 미세캡슐 제형 및 그 제조 방법
EP2343089A4 (en) 2008-09-23 2013-05-01 Jaer S A Lab USE OF XYLITOL OR DERIVATIVES THEREOF FOR MASKING THE TASTE OF CHEMOTHERAPEUTIC MEDICAMENTS OF THE CHINOLO-N-NAPHTHYRIDONE-CARBOXYLIC ACID GROUP FOR PIG DICULTINATION
US20160068527A1 (en) * 2013-04-09 2016-03-10 Cresset Biomolecular Discovery Ltd. The Treatment of Inflammatory Disorders
CN103251552B (zh) * 2013-05-30 2014-12-31 成都乾坤动物药业有限公司 一种恩诺沙星糊剂及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL266216A (xx) * 1960-07-12
GB1174221A (en) * 1968-01-08 1969-12-17 Ici Ltd Acid-addition Salts of Tetramisole
CH524372A (de) * 1969-01-29 1972-06-30 Ciba Geigy Ag Verfahren zur Herstellung von stabilen Elixieren, welche therapeutisch verwendbare tricyclische basische Wirkstoffe in Form ihrer Mononatriumpamoate enthalten
DE3525335A1 (de) * 1985-07-16 1987-01-22 Bayer Ag Embonate von chinoloncarbonsaeuren und ihren derivaten
US5281596A (en) * 1986-02-19 1994-01-25 Bayer Aktiengesellschaft Antibacterial drugs for fish
JPS62192321A (ja) * 1986-02-19 1987-08-22 Bayer Japan Kk 魚類用抗菌剤
DE3719764A1 (de) * 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
US5232919A (en) * 1987-11-13 1993-08-03 Asta Pharma Aktiengesellschaft Azelastine embonate and compositions which contain it
DE4032560A1 (de) * 1990-10-13 1992-04-16 Bayer Ag 7-(2,7-diazabicyclo(3.3.0)octyl)-3-chinolon- und -naphtyridoncarbonsaeure-derivate

Also Published As

Publication number Publication date
CA2263584A1 (en) 1998-02-26
KR100493577B1 (ko) 2005-06-10
KR20000068070A (ko) 2000-11-25
BR9711338B1 (pt) 2009-01-13
TW518226B (en) 2003-01-21
AU3942797A (en) 1998-03-06
CA2263584C (en) 2008-12-23
JP4338222B2 (ja) 2009-10-07
ES2213829T3 (es) 2004-09-01
CN1228023A (zh) 1999-09-08
MY117606A (en) 2004-07-31
US5808076A (en) 1998-09-15
BR9711338A (pt) 1999-08-17
EP0920317B1 (de) 2004-03-03
EP0920317A1 (de) 1999-06-09
DK0920317T3 (da) 2004-07-05
DE59711379D1 (de) 2004-04-08
JP2000516239A (ja) 2000-12-05
DE19633480A1 (de) 1998-02-26
ATE260657T1 (de) 2004-03-15
CN1113651C (zh) 2003-07-09
WO1998007428A1 (de) 1998-02-26
AR008304A1 (es) 1999-12-29

Similar Documents

Publication Publication Date Title
HK1022435A1 (en) Orally applicable formulation of quinolone or naphthyridone carboxylic acids
AU4864493A (en) Quinolone carboxylic acids
NZ250762A (en) Five-membered-heterocyclic carboxylic acid derivatives and pharmaceutical compositions
NO940039D0 (no) Chinolon- og naftyridonkarboksylsyrederivater
AU2110000A (en) Use of substituted isoxazol carboxylic acids and derivatives and novel substances
AP9901649A0 (en) Salt of naphthyridine carboxylic acid derivatives
IL126027A0 (en) Novel carboxylic acid derivatives their preparation and use
IL128096A0 (en) Arylcycloalkane carboxylic esters their use pharmaceutical compositions and preparation
IL126026A0 (en) Novel carboxylic acid derivatives their preparation and their use
AU7940598A (en) Quinolone carboxylic acid derivatives
HU9600322D0 (en) Novel quinolone carboxylic acid derivatives
AU697025B2 (en) Quinoline carboxylic acid
IL115594A0 (en) Preparation of alpha-tertiary carboxylic acid esters
ZA932944B (en) Quinolone carboxylic acid derivatives and process for preparing the same
PL335601A1 (en) Derivatives of 2-substituted benzoylcycloalkyl carboxylic acid
AU5814696A (en) The preparation of carboxylic acid derivatives
AU2391192A (en) Novel quinolone carboxylic acid derivatives
NO305838B1 (no) FremgangsmÕte og mellomprodukter for fremstilling av naftyridonkarboksylsyresalter
WO1998026768A3 (de) Verwendung von 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-chinoloncarbonsäure- und -naphthyridoncarbonsäure-derivaten zur therapie von helicobacter-pylori-infektionen und den damit assoziierten gastroduodenalen erkrankungen
HUP9701298A3 (en) Coumarin quinolone carboxylic acids, process for preparation thereof and their use
HU9902548D0 (en) Process for preparing quinolone and naphthyridone carboxylic acids
IL113227A0 (en) Process for the preparation of carboxyarenesulfonic acids and their carboxylic acid derivatives
NO944365D0 (no) 1-(2-fluorcyklopropyl)-chinolon- og naftyridonkarboksylsyrederivater
AU3076295A (en) Heterocyclyl-1-phenyl substituted quinolone carboxylic acids as antiviral agents
HUP9901338A3 (en) Method for making quinolone carboxylic acids or naphthyridine carboxylic acids in free base form

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100807